Know a great AI tool or AI news source? Submit it to AiByts
Coinbase Global3 min read

Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry

Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S.

By Duncan RileySiliconANGLE
Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry

Read the full story

Originally published by SiliconANGLE on Oct 22, 2026.

Read on SiliconANGLE(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.